Cabergoline and Hydroxyethyl Starch in Ovarian Hyperstimulation Syndrome Prevention
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether, in GnRH agonist in vitro fertilization (IVF)
cycles, where there is a risk of ovarian hyperstimulation syndrome (OHSS), the addition of
cabergoline to the hydroxyethyl starch infusion could decrease OHSS incidence and severity.